The reopening of the Chinese economy after the pandemic could present investment opportunities for those interested in the Chinese market.
MTQ Corporation SGX:M05 presents an attractive investment opportunity with its strong financials and potential for business turnaround.
With an attractive valuation, positive financial outlook, and commitment to innovation, Wabash National $WNC is positioned for success.
Why I remain optimistic on Regis Corporation's ($RGS) successful turnaround through cost-cutting, and growth initiatives under new management.
I covered Haw Par Group back in 2019. Hence I think it is time to revisit this company which is trading at multi year lows.
My annual investment review for 2022. This year has been a rollercoaster for the stock market, here are the key takeaways from my portfolio.
We study uniQure NV ($QURE), a biotechnology company focused on developing gene therapies for rare diseases.
VolitionRx is commercially introducing a product with a huge addressable market. If successful, the market will rerate the stock.
uniQure's AMT-061 is currently the world's most expensive drug. Here's why investing in $QURE may be rewarded with strong returns.
Here is my summary and review of "Insider Buy Superstocks". It has some important concepts to achieve great investment returns.